Reuters logo
BRIEF-Cardiome announces agreement with Basilea
September 12, 2017 / 11:13 AM / 2 months ago

BRIEF-Cardiome announces agreement with Basilea

Sept 12 (Reuters) - Cardiome Pharma Corp:

* Cardiome announces agreement with Basilea for distribution of Zevtera®/Mabelio® (Ceftobiprole) in Europe and Israel

* Cardiome Pharma- under agreement, Basilea has granted cardiome an exclusive license to commercialize Ceftobiprole in 34 European countries and Israel

* Cardiome Pharma Corp - Cardiome will provide Basilea with upfront payment, additional milestone payments based upon achievement of certain milestones Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below